These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. Metzger AL; Singer FR; Bluestone R; Pearson CM N Engl J Med; 1974 Dec; 291(24):1294-6. PubMed ID: 4215021 [No Abstract] [Full Text] [Related]
6. The use of a diphosphonate in para-articular ossifications after total hip replacement. A clinical study. Slooff TJ; Feith R; Bijvoet OL; Nollen AJ Acta Orthop Belg; 1974; 40(5-6):820-8. PubMed ID: 4219966 [No Abstract] [Full Text] [Related]
7. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. Smith R; Russell RG; Woods CG J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090 [TBL] [Abstract][Full Text] [Related]
8. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate. de Vries HR; Bijvoet OL; Froeling PG J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820 [No Abstract] [Full Text] [Related]
9. The role of diphosphonates in osteoporosis of disuse. Lane JM; Steinberg ME J Trauma; 1973 Oct; 13(10):63-9. PubMed ID: 4200554 [No Abstract] [Full Text] [Related]
10. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans]. Gennari C; Orlandini GA; Nuti R; Francini G Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911 [No Abstract] [Full Text] [Related]
11. Aberrant ossification halted after head trauma. Macek C JAMA; 1983 Feb; 249(8):993. PubMed ID: 6401825 [No Abstract] [Full Text] [Related]
12. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. Stover SL; Niemann KM; Miller JM J Bone Joint Surg Am; 1976 Jul; 58(5):683-8. PubMed ID: 819446 [TBL] [Abstract][Full Text] [Related]
13. Editorial: Diphosphonate treatment in bone disease. Fleisch H; Bonjour JP N Engl J Med; 1973 Dec; 289(26):1419-20. PubMed ID: 4201877 [No Abstract] [Full Text] [Related]
14. [Positioning of bisphosphonates for vascular calcification]. Okada Y; Mori H; Tanaka Y; Hashimoto O Clin Calcium; 2010 Nov; 20(11):1711-7. PubMed ID: 21037392 [TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on the plaque-preventive effect of HEDP]. Herforth A Dtsch Zahnarztl Z; 1976 May; 31(5):392-5. PubMed ID: 820542 [No Abstract] [Full Text] [Related]
17. [Heterotopic ossification and vascular compression]. Gallien P; Nicolas B; Le Bot MP; Robineau S; Rivier I; Sarkis S; Brissot R Rev Rhum Ed Fr; 1994 Dec; 61(11):823-8. PubMed ID: 7858577 [TBL] [Abstract][Full Text] [Related]
18. [Prevention of calcifications by the use of EHDP after total hip prosthesis operations]. De Bastiani G; Tarolli G; Bellamoli S Chir Organi Mov; 1979; 65(5):525-30. PubMed ID: 122302 [No Abstract] [Full Text] [Related]
19. [Tumerous calcinosis (Teutschlander's lipocalcinogranulomatosis). Long term observation and therapy with diphosphonates]. Leicht E; Tkocz HJ; Seeliger H; Lauffenburger T Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1349-52. PubMed ID: 417489 [No Abstract] [Full Text] [Related]
20. The effects of disodium ethane-hydroxy-1,1-diphosphonate and disodium dichloromethylene diphosphonate on lanthanide-induced calcergy. McClure J J Pathol; 1982 Jun; 137(2):159-65. PubMed ID: 6211530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]